NBCL has developed a point of care analyzer with a five-minute whole blood intact PTH assay that can be operated by anyone. NBCL offers assay development for your biomarkers on the NBCL point of care analyzer or on your platform.
Company Details
- Employees
- 21
- Founded
- -
- Address
- Kerkenbos 1097-C, Nijmegen,gld 6546bb,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nbcl.nl
- Keywords
- Assay Design, Assay Development, Point of care, Endocrinology, Troponin I, POC, PTH, Cortisol, hs-troponin, high-sensitivity troponin, NT-proBNP, D-Dimer, hs-troponin I, Surgery, Interventional Radiology, Contract assay development, Intraoperative PTH, Intraporcedural Cortisol, HCVcAg, PCT, Emergency department.
- HQ
- Nijmegen, GLD
Nbcl - Novel Biomarkers Catalyst Lab Questions
Nbcl - Novel Biomarkers Catalyst Lab's website is nbcl.nl
Nbcl - Novel Biomarkers Catalyst Lab's LinkedIn profile is https://nl.linkedin.com/company/nbcl-b-v-
Nbcl - Novel Biomarkers Catalyst Lab has
21 employees.
View email and phone details for 21
employees at Nbcl - Novel Biomarkers Catalyst Lab.
Nbcl - Novel Biomarkers Catalyst Lab's industry is
Biotechnology Research
Nbcl - Novel Biomarkers Catalyst Lab's top competitors are
Lacar Mdx Technologies,
Enzyre B.v.,
Nytor,
Medical-X,
Orthros Medical,
Csr Biotech,
Future Diagnostics Solutions,
Qvq Holding Bv,
Hcm Medical,
Complement Pharma.
Nbcl - Novel Biomarkers Catalyst Lab's categories are Biotechnology Research
Nbcl - Novel Biomarkers Catalyst Lab's founding year is 2012
